Guía de Práctica Clínica sobre Lupus Eritematoso Sistémico

215 Ho a, Barr SG, Magder LS, Petri M. A decrease in complement is associated with
increased renal and hematologic activity in patients with systemic lupus erythematosus.
Arthritis Rheum 2001; 44: 2350–2357.
216 Gunnarsson I, Rönnelid J, Huang YH, Rogberg S, Nilsson B, Lundberg I et al.
Association between ongoing anti-C1q antibody production in peripheral blood and
proliferative nephritis in patients with active systemic lupus erythematosus. Brithish J
Rheumatol 1997; 36: 32–37.
217 Sjoholm A, Martensson U, Sturfelt G. Serial analysis of autoantibody responses to the
collagen-like region of Clq, collagen type II, and double stranded DNA in patients with
systemic lupus erythematosus. J Rheumatol 1997; 24: 871–878.
218 Siegert C, Daha M, Westedt M, van der Voort E, Breedveld F. IgG autoantibodies against
C1q are correlated with nephritis, hypocomplementemia, and dsDNA antibodies in
systemic lupus erythematosus. J Rheumatol 1991; 18: 230–234.
219 Becker GJ, Waldburger M, Hughes GR V, Pepys MB. Value of serum C-reactive protein
measurement in the investigation of fever in systemic lupus erythematosus. Ann Rheum
Dis 1980; 39: 50–52.
220 Stojan G, Fang H, Magder L, Petri M. Erythrocyte sedimentation rate is a predictor of
renal and overall SLE disease activity. Lupus 2013; 22: 827–834.
221 Vilá LM, Alarcón GS, Mcgwin G, Bastian HM, Fessler BJ, Jr GM et al. and damage
accrual . Systemic Lupus Erythematosus in a Multiethnic Cohort (LUMINA): XXIX .
Elevation of Erythrocyte Sedimentation Rate Is Associated with Disease Activity and
Damage Accrual. J Rheumatol 2005; 32: 2150–2155.
222 Mirzayan MJ, Schmidt RE, Witte T. Prognostic parameters for flare in systemic lupus
erythematosus. Rheumatology 2000; 39: 1316–1319.
223 Ng WL, Chu CM, Wu a KL, Cheng VCC, Yuen KY. Lymphopenia at presentation is
associated with increased risk of infections in patients with systemic lupus erythematosus.
QJM 2006; 99: 37–47.
224 Ciruelo E, de la Cruz J, López I, Gómez-Reino JJ. Cumulative rate of relapse of lupus
nephritis after successful treatment with cyclophosphamide. Arthritis Rheum 1996; 39:
2028–2034.
225 Illei G, Takada K, Parkin D. Renal flares are common in patients with severe proliferative
lupus nephritis treated with pulse immunosuppresive therapy. Arthritis Rheum 2002; 46:
995–1002.
226 Mok CC, Ying KY, Tang S, Leung CY, Lee KW, Ng WL et al. Predictors and outcome of
renal flares after successful cyclophosphamide treatment for diffuse proliferative lupus
glomerulonephritis. Arthritis Rheum 2004; 50: 2559–2568.
227 Moroni G, Quaglini S, Maccario M. Nephritic flares are predictors of bad long-term renal
outcome in lupus nephritis. Kidney Int 1996; 50: 2047–2053.
GUÍA DE PRÁCTICA CLÍNICA SOBRE LUPUS ERITEMATOSO SISTÉMICO 451